Autonomic Nervous System





Origin: Neurotransmitters

- Preganglionic always Ach
- Parasympathetic always Ach
- Postganglionic sympathetic β Norepinephrine
- Except β Sweat glands β Ach
Category | Neurotransmitter |
Preganglionic parasympathetic | ACh |
Preganglionic sympathetic | ACh |
Postganglionic parasympathetic | ACh |
Postganglionic sympathetic | NA (at all places), ACh (at sweat glands) |
Actions: Location Parasympathetic Sympathetic
Location | Parasympathetic | Sympathetic |
Heart | ββ | +++ |
Bronchus | Bronchoconstriction | Bronchodilation |
GIT | Diarrhea | Constipation |
Bladder | Contract | Relax |
Glands | β Secretions | β Secretions |
Pupil | Miosis | Mydriasis |
Sexual system | Erection | Ejaculation |
- Mnemonic:
- Sympathy β only in heart β only stimulate heart
- Sexual β Point (Erection β parasympathetic) and shoot (Ejaculation β Symp)
Erection | γ
€ | γ
€ |
Mechanism | Parasympathetic (S2, S3, S4 roots) | Non-adrenergic non-cholinergic (NANC) system |
Mediated by | Acetylcholine | Nitric oxide β’ Dilatation of arterioles β’ Compression of outflow veins β’ Engorgement & erectionΒ (Acts viaΒ cGMP) |
Ejaculation | γ
€ | γ
€ |
Mechanism | Sympathetic | γ
€ |
PARASYMPATHETIC SYSTEM
- Major neurotransmitter is ACh.
- It works on cholinergic receptors.
Cholinergic Receptors

- Botulinum toxin β Prevent release of Acetyl choline β β Acetyl choline at synapse
- Physostigmine β Inhibit acetylcholine esterase β β Acetyl choline at synapse
- Mnemonic:
- Ach = Parasympathetic
- Boatil β Cola kittilla (Ach ββ) β ββ Parasympathetic
- Flight β Cola kittum (Ach ββ) β ββ Parasympathetic
Muscarinic Receptor
- M1
- Stomach: βHCl
- M2
- Heart:
- β HR
- β Conduction
- M3
- Bronchus: BC
- GIT: β Peristalsis
- Bladder: β Contraction
- Glands: β Secretions
- Pupil: Miosis
- Muscle Ondel β Relax
- Muscle indavan
- 1st (M1) β Eat β β HCl
- 2nd (M2) β Do Cardio β HR ββ
- Then Others
- Mnemonic: First eat food (M1 β Stomach) β then manassu nirayum (M2 β heart) β then rest (M3 β Rest)

Significance

- Respiratory Failure causing conditions
- Action on Neuromuscular Receptors:
- Aminoglycosides:
- Muscular Contraction (Lower Ach)
- Neuromuscular Toxicity
- DOC: Ca2+
- Krait Bite:
- Ξ² bungarotoxin
- Mnemonic: There was a krait () in Bunglow (bungarotoxin)
- Myasthenia Crisis
- Cobra Toxin
- Food Poisoning: Botulinism
- Flappy Infant Syndrome
- Mnemonic: Floppy Boat
- Mx: Ventilation
Uses of Botulinum:
- Tardive Dyskinesia (Torticollis/Cervical Dystonia):
- Injected into SCM
- Urge Incontinence/Overactive Bladder
- Cosmetic:
- To remove glabellar lines

- Unrelaxed LES:
- Achalasia
- Migraine Prophylaxis:
- D/T β CGRP (Calcitonin gene-related peptide) Release
Mnemonic:
- Nicotine (Nicotinic) adich Music (Muscarinic) keett nadakkunnavar β Para
- Ξ± and Ξ² males β Sympathetic
CHOLINERGIC DRUGS:
Directly Acting Cholinergic Drugs:
DRUG | ACTS ON | ACTION | INDICATION |
Pilocarpine | Pupil [M3] | Miosis | Angle closure glaucoma |
- Mnemonic: pILOCarpine β COLI β Cholinergic
Indirectly Acting Cholinergic Drugs
- Acetylcholinesterase (AChE) Inhibitors
- Reversible AChE inhibitors are used clinically
- irreversible AChE inhibitors are toxic.
1. Reversible AChE Inhibitors

Category | Details |
Lipid Soluble Drugs | Cross BBB Dona Galavanting Near a River β Applying Oil (Lipid) β Saw in Flight (Physostigmine) |
Physostigmine | Atropine poisoning Glaucoma |
Donepezil (D) Rivastigmine (R) Galantamine (Gobind) | Alzheimer's disease |
Water Soluble Drugs | γ
€ |
Treatment: Neostigmine, Pyridostigmine Diagnosis: Edrophonium β bcz it is short acting Mnemonic: New () Periods () β Flowing like Hydro (Edrophonium) | Myasthenia Gravis Drugs avoided in MG Digene antacids β contain magnesium or aluminum salts β reduce the effectiveness of pyridostigmine Lidocaine worsening the symptoms of myasthenia gravis |
- Atropine = Antimuscarinic
Uses of Neostigmine

γ
€ | Nicotinic βΊ Muscle (NMJ) related | Muscarinic Uses βΊ Visceral related |
MOA | Used in Lower Activity of Nm receptors To β Acectyl choline | γ
€ |
Uses | Myasthenia gravis Cobra bite Reversal of muscle relaxants (NMDR receptors) | Post operative Urinary retention |
Notes | Atropine Added Muscarinic inhibitor β Neutralise muscarinic side effects caused by Neostigmine | Atropine is not added |
- Neostigmine β Nicotine vachal
- Public place urination β Post op urinary retention
- Walk showing My Ass β Myasthenia Gravis
- Catch cobra β Cobra bite
Edrophonium Test (Tensilon Test)
- Used to differentiate between Myasthenia and Cholinergic crisis.
- IV Edrophonium given.
β Very short acting [<10 min]
- If the condition improves for 10 min
- Myasthenia gravis.
- If the condition worsens for 10 min
- Cholinergic crisis.
- Mnemonic: Tension ollapo Edraa phone β 10 minitil
2. Irreversible AChE Inhibitors
- Organophosphates
- Malathion
- Parathion
- Sarin
- Sabin
- Carbamates
- Carbaryl
- Propoxur
Organophosphate Poisoning
- Competitive Irreversible inhibition of Acetylcholine esterase
Clinical Features
Receptor Stimulated | Feature |
M1 | Gastric Acidity |
M2 | Bradycardia and Hypotension |
M3 | Pinpoint pupil Increased Secretions Diarrhea Urination Bronchoconstriction |
M1, M2, M3 | Coma |
NM | Muscle weakness |
NN | Tachycardia and Hypertension |
- Note:
- Nicotinic symptoms are extremely rare.
- Pinpoint pupil with increase in secretions usually indicates OP poisoning.
Treatment
1. Atropine
- Drug of choice for OP and Carbamate poisoning.
- Note: Atropine is not used in organochlorine (endrin) poisoning.
- Can reverse Muscarinic effects of OP
- Cannot reverse Nicotinic action β muscle weakness.
- Given via IV route every 5 minutes
- until atropinization signs appear
- Signs of Atropinization
- Decreased Secretions (Most reliable, Most specific).
- Mydriasis (Most commonly used sign).
- Tachycardia (Heart Rate > 100 bpm).
Note
- Atropin also used in mushroom poisoning
2. AChE Reactivators (Oximes)
- Not drug of choice.
- Pralidoxime [PAM]
- PAM β peripherally
- Mnemonic: P for P
- Di AcetylMonoxime [DAM]
- DAM β both central and peripheral actions
- Mnemonic: D for Di action β 2 action β peripheral and central
- Only effective in OP poisoning.
- Mnemonic: OOO β oximes only in OP poisoning
- Not uses in Carbamate poisoning
Note
Carbamate poisoning
- Oximes not used
- Intermediate syndrome is seen
- No aging
- Less CNS toxicity
Anticholinergic Drugs
Organ | Receptor Blocked | Drugs | Uses |
Stomach | M1 | Pirenzepine Telenzepine | Peptic ulcer Pyru (Pirenzepine) Thoran (Telenzepine) thinnapo Acid poi |
Heart | M2 | Atropine (DOC) | Bradycardia AV block |
Bronchus | M3 | Ipratropium | Bronchial asthma |
γ
€ | γ
€ | Tiotropium | COPD |
Bladder | M3 | Solifenacin (S) Oxybutynin (O) Flavoxate (F) Tolterodine (T) Darifenacin (Dar) | Overactive bladder Mnemonic: SOFT bladDAR Flavor (Flavoxate) ulla feni (Darifenib) kudichitt β Overactive (Oxybutynin) ayi β Soli (Solifenib) de tholil (Tolterodine) keri β |
Eye | M3 | Atropine (?Homatropine) Longest acting β DOC in children - Atropine eye ointment | Fundoscopy (d/t Mydriatic action) Refraction testing (d/t Cylcoplegic action) |
γ
€ | γ
€ | Cyclopentolate | Iridocyclitis |
γ
€ | γ
€ | Tropicamide Shortest acting β DOC for adults | Mydriatric for fundoscopy |

Atropine Poisoning: (Anticholinergic Poisoning)
- Patient presents with history of taking wild fruit (Dhatura/Belladonna).

- Signs/Symptoms (DRYD HEAT)
- D - Dry mouth, Delirium
- H - Hyperthermia
- A - Agitation
- T - Tachycardia
- U - Urinary Retention
- R - Restlessness
- A - Accommodation lost (Blurred vision, Photophobia)
- DOC for treatment: Physostigmine.
Sympathetic Nervous System

- Major neurotransmitter: Noradrenaline.
Adrenergic Receptors
Receptor | Location | Action |
Ξ±1 | Blood vessels | Vasoconstriction |
Ξ± male Always eyes open (Mydriasis). Always high pressure β constricted blood vessels (). Dont urinate () in public (prostatic). | Eye | Mydriasis |
γ
€ | Prostatic urethra | Decreased outflow |
Ξ±2 | BRAKE (Acts like brake to sympathetic system) | Presynaptic receptor |
Beta Receptors
- Beta β Think of Child birth
- 1st β Janikkum (JG) β HR nokkum (Heart)
- 2nd β Baaki ellam nokkum
- 3rd β weight kurayunnundo (Lipolysis) β Urine pass cheyyunnundo (Prostatic urethra)
Ξ²2
Location | Action |
Lungs | Bronchodilation |
GIT | Constipation |
Bladder | β Outflow |
Glands | β Secretions |
Uterus | Tocolytic |
Blood vessels | Vasodilation |
Skeletal muscle | Tremors |
Liver | β Blood sugar |
- Mnemonic: Important
- ACBD β Blood Vessels only
- Ξ±1 β Constrict
- Ξ²2 β Dilate
Ξ²1
Location | Action |
Heart | β HR, BP |
JG cells | Renin secretion |
Ξ²3
Location | Action |
Fat | Lipolysis |
Bladder | Relax |
- Ξ²3 stimulant β given for overactive bladder β Mirabegron
- Mnemonic: Mera bladder gone

Effect on Hypoglycemia

- Mnemonic:
- Beta Beta Mone 123
- Sympathetic system protects from hypoglycemia by two mechanisms:
1. Warning Symptoms | 2. Hypoglycemia Reversal |
Tachycardia (Ξ²1) | By changing metabolism (Ξ²2) Glycogenolysis Gluconeogenesis |
Palpitations (Ξ²1) | γ
€ |
Tremor (Ξ²2) | γ
€ |
Sweating (M3) | γ
€ |
- Beta blockers
- Mask hypoglycemia warning symptoms
- Prevent reversal of hypoglycemia.
- Contraindicated in diabetic patients.
- Sweating is the only reliable symptom
Adrenergic Drugs
- Divided into:
- Indirectly Acting Drugs
- Directly Acting Drugs
Indirectly Acting Drugs
Cocaine
- Acts by inhibiting reuptake of Noradrenaline.
- 2 actions
- Local anaesthetic
- Causes vasoconstriction and hypertension.
- all other LA β vasodilation
- Addictive drug.
- Tactile hallucinations ("cocaine bugs"):Β Scratching of skin.
- Causes palatine perforation.
- Overdose characterized by:
- Agitation
- Ulcers or scratch marks on skin
- Sympathetic symptoms
- Tachycardia,
- Mydriasis,
- Hypertension,
- MI
Directly Acting Drugs
- Catecholamines
- Non Catecholamines
1. Catecholamines
- Not effective orally.
Endogenous | Exogenous |
Adrenaline (Ξ±1, Ξ±2, Ξ²1, Ξ²2) Mnemonic: A for all () | Dobutamine (Ξ²1) Mnemonic: ButtamOne β Ξ²1 |
NA (Ξ±1, Ξ±2, Ξ²1) Mnemonic: NA β Not all | Isoprenaline (Ξ²1, Ξ²2) Mnemonic: Isoprenaline β half of adrenaline |
Dopamine (D1, Ξ²1, Ξ±1) Mnemonic: DoBaOne (D1, Ξ²1, Ξ±1) | Fenoldopam (D1) For Dopa β always D1 |


Adrenaline uses
- Anaphylactic Shock
- DOC
- Route of choice: IM or SC.
- Concentration: 1:1000
- 0.5 ml
- Cardiac Arrest
- CPR is done first.
- Adrenaline is useful.
- Concentration: 1:10,000 (0.1 mg/mL)
- 10 mL in cardiac arrest
- 1 mL in Anaphylaxis
- Preferred routes: IV > Intraosseous > ET.
- With LA
- decrease systemic toxicity and increase duration of action.
- 1:1,00,000 - 1:2,00,000.
Noradrenaline uses
- Septic Shock: DOC.
- Effect monitored by checking mean blood pressure.
Summary
- Vasoconstriction β BP β β Vagal stimulation β Reflex β HR
- Adrenaline β β HR and β BP
- Direct β cardiac contractility (Ξ²1)
- so it overcomes Reflex bradycardia
- DOC in anaphylactic shock
- NA β βBP and βHR
- Potent vasoconstriction (Ξ±1)
- Reflex bradycardia result in β HR
- But in denervated or atropinised heart
- No reflex bradycardia β ββ HR
- Used in Medical ICU β In shock (except anaphylactic shock)
- Isoprenaline β βBP and βHR
- In CHB
- Used in Cardiac ICU
Dopamine
- Acts on: DoBBAAOne
Dose (mcg/kg/min) | Receptor | Organ | Action | Mnemonic |
< 2 | D1 | Blood vessels | Vasodilation (β in Renal flow) | Do β DIlate |
2-10 | Ξ²1 | Heart | HR ββ | Baβ Pa β Pump |
> 10 | Ξ±1 | Blood vessels | Vasoconstriction | Mine β constrict |
- Uses:
- CHF β Cardiogenic shock
- Dobutamine β First-line if BP adequate
- Dopamine β If mild hypotension
- Norepinephrine β If severe hypotension
- Shock + Oliguria (DOC)
- Drug with βdopaβ in their name acts on D1, others do not
- So Dopa in name β D1 stmulation β β Urine O/p
Drug | Mechanism of Action | Clinical Use |
Dobutamine | Acts on Ξ²β receptors | Used for CHF |
Dopexamine | Stimulates Dβ, Ξ²β, and Ξ²β receptors; inhibits reuptake of NA | Used for CHF |
Fenoldopam | Stimulates only D1 receptors | Used in hypertensive emergencies |
Dobutamine β Drug of Choice in
- Cardiogenic shock with low cardiac output and normal or high BP
- Acute decompensated heart failure (ADHF)
- Stress echocardiography (pharmacologic stress test)
2. Non-Catecholamines

Stimulates | Drugs | Action |
Ξ±1 | Phenylephrine eye drops | Active Mydriasis without cycloplegia |
γ
€ | Methoxamine | Vasoconstriction (Used in shock) |
γ
€ | Mephentermine | ββ |
γ
€ | Xylometazoline | Nasal decongestants |
γ
€ | Oxymetazoline | ββ |
γ
€ | Naphazoline | ββ |
Ξ±2 | Clonidine | Brake for sympathetic system |
γ
€ | Methyldopa | Used for hypertension |
Ξ²2 | Salbutamol | Bronchodilation |
γ
€ | Terbutaline | Used for asthma by inhalational route |
γ
€ | Salmeterol | γ
€ |
γ
€ | Formoterol | γ
€ |
γ
€ | Ritodrine | Uterus (-) β Tocolytic Used for preterm labor |
γ
€ | Isoxsuprine | ββ |
Ξ²3 | Mirabegron | Overactive bladder |

- Note: Beta-2 agonists can cause following adverse effects:
- T - Tremors
- T - Tachycardia
- T - T-wave changes in ECG (due to hypokalemia)
- Pulmonary edema (by ritodrine)
- Hyperglycemia
- However, Ξ²2 agonists do not cause hypoglycemia.
Clonidine
- Mnemonic: Clonidine β Clutch β Brake
- Brake poyapo (Clonidine withdrawal) β Vandi idich β Pantilu Thola veenu (Phentolamine)
- Mechanism
- Central acting alpha 2 agonist
- β Sympathetic outflow β β Blood pressure
- Uses
- Hypertension
- Opioid withdrawal
- Smoking cessation
- Withdrawal symptom relief:
- β Cravings
- β Anxiety
- β Irritability
- Rebound Hypertension
- Cause
- Abrupt discontinuation of clonidine
- Leads to:
- Upregulation of alpha-1 receptors
- Reduced alpha-2 receptor activity
- β Sympathetic activity β No BRAKE β ββ BP
- Symptoms
- Sudden, marked rise in BP
- Headache
- Dizziness
- Confusion
- DOC: Phentolamine
Norepinephrine Displacers
Mechanism of Action
- Drug (Similar to NE) enters neuron
- NE molecule displaced from vesicle β Synaptic space β Alpha & Beta stimulation β Sympathomimetic effect
- Eg: Tyramine in cheese and wine
Dosing
- Intermittent Dosing
- NE acts on Alpha & Beta receptors
- Sympathomimetic effects
- Continuous Dosing
- Depletion of NE
- Failure of drug & sympatholysis
Metabolism
- NE is metabolised by monoamine oxidase.
Clonidine Suppression Test:
- Performed using 0.3 mg clonidine (Alpha 2 agonist).
- Acts on presynaptic receptors to prevent catecholamine release.
- Medications to stop before Screening Test:
- Tricyclic anti-depressants.
- L Dopa.
Cheese Reaction

- Patient eats together
- Tyramine containing food
- (Cheese, wine, etc.)
- Displacement of NE
- MAO Inhibitors
- (Anti-depressants)
- NE not metabolised
- Accumulation of NE
- Hypertensive crisis
- DOC: Phentolamine
- Mnemonic: A depressed patient taking MAO I β celebrates New year (cheese and wine) β comes to EM with β BP
Anti-Adrenergic Drugs
These may be:
- Alpha blockers
- Ξ² - Blockers
ALPHA BLOCKERS
These can be:
- Non-selective (Ξ± 1 + Ξ± 2) blockers
- Selective Ξ± 1 blockers
a. Non-Selective Ξ± Blockers
- Used in severe hypertension.
- Can cause severe tachycardia.
- Irreversible
- Phenoxybenzamine
- Used for Pheochromocytoma.
- Reversible
- Phentolamine
- Used for:
- Cheese Reaction
- Clonidine withdrawal
- Tolazoline
- Tola valuthakkan
- Dilatation of small blood vessels
- For PVD
- Beurgers ds
- Raynauds ds β Preferred β CCB
- Angiography
b. Selective Ξ±1 Blockers
- Osins
- Used in mild to moderate hypertension.
- No severe tachycardia.
- Drugs
- Prazosin
- D.O.C Scorpion sting
- Terazosin
- Doxazosin
- Alfuzosin
- Types of Ξ± 1 receptors
- Ξ± 1A
- Mnemonic: Ξ± male β Publcil muthram ozhikkilla β A kanikilla
- On Prostatic Urethra
- Eg Tamsulosin, Silodosin
- No postural hypotension
- DOC for normotensives with BPH
- Ξ± 1B/1D
- On Blood Vessels
Adverse Effect
- First Dose β cause Postural Hypotension
- Ξ±1 blockers always started at bed-time.
Benign Prostatic Hyperplasia: (BPH)
Ξ± 1A blockers:
- Tamsulosin
- Stops the dynamic component
- Reduces muscle tone
- Do not affect the size of prostate
- Are only for the symptoms of BPH
- Adverse effects:
- dizziness, dry mouth, dry ejaculations.
5-Ξ± reductase inhibitors:
- Finasteride
- Highly Teratogenic
- Static Component
- Stops the conversion of Testosterone to DHT
- Control/stops the growth of Prostate in BPH
- Decreases prostate volume.
- 50% reduction in PSA within 6 months.
- Mnemonic: Finasteride is not a fun ride when you have erectile dysfunction.
BETA (Ξ²) BLOCKERS
- Beta-1 + Beta-2 # (First Generation)
- Cardiac and non-cardiac uses.
- Contraindicated in:
- Asthma
- DM
- PVD
- Beta-1 # (Second Generation)
- Only cardiac uses.
- Relatively safe.
1. Cardio-Selective or 2nd Generation Beta

- New β Nebivolol
- Beta β Betaxolol
- Blockers β Bisoprolol
- Act β Acebutolol
- Exclusively β Esmolol
- At β Atenolol
- Myo β Metoprolol
- Cardium β Celiprolol
- These are relatively safe in:
- Asthma
- PVD
- DM
2. Intrinsic Sympathomimetic Activity [ISA] or Partial Agonists
- Less chances of causing severe bradycardia
- Contain β Celiprolol
- Partial β Pindolol
- Agonist β Alprenolol (Alpam)
- Activity β Acebutolol
1st generation
- 1st generation doctors β Proper Sota Time Nahi
- Propranolol
- Sotalol
- Timolol
- Nadolol



Other Mnemonic:
- CARvedilol β Ca blocker, Ξ± blocker, Reducing Oxidation (Antioxidant)
- LABetolol β Alpha and Ξ² blocker
- TILisolol β Tile Potti Open ayi (Potassium opener)
- Sotalol β Close to Pottan (Close Potassium) β QT Prolongation
- Propanolol β Proper Sodium β Proper anasthesia
- NO releasing β Nebi Cealingilkude (celiprolol) Nadannu β Nebivolol, Nadalol

Vasodilation via
Property/Mechanism | Examples | Notes |
Alpha Blocking | Carvedilol, Labetalol | Labetalol is most common Alpha nem beta nem (Ξ± + Ξ² Blocker) orumich car (carvedilol) vach labilot (Labetolol) idich keeti |
Nitric Oxide (NO) Release | Nebivolol Nadolol (Nadannu β Longest Action) | γ
€ |
CCB-like (Mimic CCBs) | Carvedilol | γ
€ |
Na+ Channel Blockers | Propranolol Carvedilol Metoprolol (Paralyse Cell Membrane) | Exhibits maximum effect MOA: Local Anesthetic Effect Membrane Stabilizing Effect Contraindicated (C/I) in Glaucoma |
Indications
Other Applied Aspects
Hypertrophic Obstructive Cardiomyopathy (HOCM)
- MOA of drug:
- ββ heart contraction β
- ββ LVOT obstruction.
- Treatment (Rx):
- Medical:
- Metoprolol
- If no response, consider CCBs:
- Verapamil or Diltiazem.
- If no response, try Ranolazine.
- Surgical:
- Septal resection.
- Contraindication (C/I):
- Digoxin:
- Increases force of contraction
- Worsens HOCM
Adverse Effects and Contra-indications
- Due to Ξ² 1 Blockade
- β Rate β Bradycardia (C/I in Sick sinus syndrome)
- β Conduction β AV Block
- β Contractility β Acute CHF
- Due to Ξ² 2 Blockade
- Asthma
- Peripheral vascular Disease
- Diabetes mellitus
- Variant angina.
Carvedilol
- Non selective
- Cardioprotective antioxidant
- Maximum Plasma Protein binding
- Minimum:Β Celiprolol
- Used in hepatic venous pressure reduction
- Alpha β activity
- Intra hepatic vasodilatation
- NonSelective BetaBlocker of choice for prophylaxis of variceal bleeding in high-risk cases.
- Mnemonic: Carvedilol crave for proteins
- CARvedilol β Ca blocker, Ξ± blocker, Reducing Oxidation (Antioxidant)
- MOA: Ca channel blocker
Nebivolol
- Most cardioselective & Cardioprotective
- 3rd generation
- MOA: β NO
Esmolol
- Half-Life (TΒ½)
- Longest:Β Nadolol
- Mnemonic: Kore Nadannu
- Shortest:Β Esmolol
- Mnemonic:
- Esmolol β Esterases, Small
- Esma β Asthma, Surgery
- Metabolised by esterases
- DOC in
- IntraoperativeΒ blocker
- Aortic dissection as combination therapy
- Ξ² blocker in Asthmatics
- Less risk of bronchoconstriction
Aortic Dissection
- Advantage of Treatment:
- β BP
- Reduces risk of aneurysmal rupture.
- Treatment (Rx):
- Esmolol
- Plus Nitroprusside.
- Monotherapy (either alone) is avoided.
- Causes reflex tachycardia.
Beta-Blockers with Special Properties
Water SolubleΒ Ξ² Blockers
- Mnemonic:Β BANANAS CHIPS
- Betaxolol
- Atenolol
- Nebivolol
- Acebutolol
- Nadolol
- Sotalol
- Bisoprolol
- Celiprolol
- Characteristics
- Lipid insoluble:
- Do not cross Blood-Brain Barrier (BBB)
- No central side effects (S/E)
- Contraindication (CI)
- Renal failure
GLAUCOMA
Glaucoma is characterized by β IOP:
- It may be due to:
- β Aqueous humor production
- β Aqueous humor drainage
DRUG OF CHOICE
- POAG β Latanoprost
- Angle closure glaucoma β Acetazolamide
- Acute congestive glaucoma β Mannitol
Drug Class | Mechanism of Action |
Prostaglandin analogs | β’ β Uveoscleral outflow |
Nitric Oxide (NO) | β’ β Trabecular outflow |
Ξ²-blockers | β’ β Aqueous production |
Carbonic Anhydrase Inhibitors | β’ β Aqueous production |
Ξ±-Agonists | β’ β Aqueous production + β’ β Trabecular outflow (Apraclonidine) / β’ β Uveoscleral outflow (Brimonidine) |
Rho Kinase Inhibitor | β’ β Aqueous production β’ β Trabecular outflow via: ββ β Actin-myosin contraction ββ β β Episcleral venous pressure |
Mechanism | Drug Classes |
β Trabecular outflow | β’ Nitric Oxide β’ Ξ±-Agonists β Apraclonidine β’ Rho Kinase Inhibitor Trap β No () Trap, A clone () β its Risky () |
β Uveoscleral outflow | β’ Prostaglandin analogs β’ Ξ±-Agonists β Brimonidine UV put PGs in Brim |
β Aqueous production | β’ Ξ²-blockers β’ Carbonic Anhydrase Inhibitors (CAIs) β’ Ξ±-Agonists β’ Rho Kinase Inhibitor All inhibitors + Ξ± agonist β β Aquous pdn |
Prostaglandin F2Ξ± (PGF2Ξ±):
- Latanoprost (DOC).
- Increases uveoscleral outflow.
- Side effects:
- Hypertrichosis.
- Bimatoprost β FDA approved for hypotrichosis
- Hyperpigmentation of iris.
- Cystoid macular edema.
- Uveitis
- Contraindicated in patients with signs of uveitis
- like aqueous flare, corneal precipitants
- Reactivation of Herpes keratitis
- Take h/o previous corneal/herpetic infections
- Mnemonic:
- PGs got herpes () at a CME ().
- They are afraid of UV (Uveitis, β Uveoscleral outflow).
- Drug:Β Latanoprostene bunodΒ (Prodrug)
- MOA:Β On administration, breaks down βΒ LatanoprostΒ +Β ButadenolΒ (Unstable)
- LatanoprostΒ β βΒ Uveoscleral outflow
- Butadenol breakdown βΒ Nitric oxide ββ
- Nitric oxideΒ βΒ Relaxes trabecular meshworkΒ β βΒ Trabecular outflow
Ξ²-blockers:
- Timolol (non-selective).
- Decreases aqueous production.
- Side effects:
- Corneal anesthesia on continuous use (especially Timolol)
- Nasolacrimal duct (NLD) blockage.
- Blepharoconjunctivitis
- Aphakic cystoid macular edema:Β
- Specific to Betaxolol
- Mnemonic: Beta blocker β Beat the eye β No pain bcz corneal anasthesia () β But got NLD blockage () and Conjunctivitis ()
Ξ±-agonists:
- Apraclonidine:
- Decreases aqueous production + increases trabecular outflow.
- More preferred agent for glaucoma.
- DOC for post laser rise in IOP.
- Side effects:
- Eyelid retraction,
- mydriasis (d/t Ξ±β > Ξ±β agonism)
- follicular conjunctivitis
- Mnemonic:
- Apraclonidine β Appan β Open our eyes (Mydriasis and eye lid retraction) β Give flower (Follicular conjunctivitis) β Wipe our tears (β aquous pdn and βoutflow) β All this after laser surgery
- Brimonidine:
- Contraindicated in children and infants
- 2nd line agent for glaucoma.
- Decreases aqueous production (+ βΒ Uveoscleral outflow)
- CNS suppression due to crossing of BBB.
- Drowsiness
- apnea
- depression
- UV put everyone on Brim β Cause depression
- Not recommended for Children
Carbonic anhydrase inhibitors:
- Acetazolamide -Β emergency drug.
- Dorzolamide:Β Rx of childhood glaucoma
- MOA:
- Inhibit CA II isoform on sphincter pupillae & ciliary muscle
- βΒ Aqueous production
- Mnemonic: Car nte dooril child kudungi (Car β Dorzolamide β For childhood)
Pilocarpine
- S/E
- Miosis
- NLD stenosis
Rho kinase inhibitors:
- Netarsudil
- Dual action drug
- βΒ Aqueous production
- βΒ Trabecular outflowΒ by:
- Promoting actin-myosin contraction
- βΒ Episcleral venous pressure
- Side effects:
- Congestion/hyperemia
- Corneal verticillata: (Spindle shaped deposits)
- Subconjunctival haemorrhage
NOTE
- Vortex Keratopathy / cornea verticillata
- Whorl like/Spindle pattern
- Also seen in Queen () Ami () Tame () with Netram () in Indian () Fabric () dress
- Chloroquine
- Amiodarone
- Tamoxifene
- Netarsudil (Rho kinase β),
- Indomethacin
- Fabryβs disease
- Phenothiazines
- NOT Methotrexate

MOA OF DRUGS USED IN GLAUCOMA
Adverse Effects
MiotiCS
- Cataract
- Stenosis of NLD
PGF2Ξ± Analogues (Latanoprost)
- Pigmentation of Iris (Heterochromia Iridis)
- Growth of eyelashes (Hypertrichosis)
- Fluid in macula (Macular edema)
- Mnemonic: PGF
- Contra-indicated in uveitis
ApracLonIDine Q
- Lid retraction
Brimonidine Q
- Causes Brain suppression and ocular hypotension in Infants (Leads to Apnea)
- C/I in children < 2yrs
Netarsudil (Rho-kinase inhibitor)Q
- Cornea verticillata.
ANS PRACTICALS
1. Ileum graphQ

- Cholinergic drug β Acetyl choline
- Adrenergic drug β Epinephrine
2. Atropine & Acetylcholine experiment


- (A) + (B): ACh Action
- Vasodilation (m3) β β BP
- (C): ACh + Atropine
- Atropine blocks m3 receptors.
- Results in no effect on blood pressure.
- (D): High Doses of ACh + Atropine
- Stimulate Preganglionic Nn receptors.
- Releases norepinephrine β Vasoconstriction (Nn) β β BP
- Summary
- Acetylcholine alone β β BP
- Acetylcholine (low dose) + Atropine β No change in BP
- Acetylcholine (high dose) + Atropine β ββ BP
- Nicotinic/sympathetic action appear
3. Dale's Phenomenon

- Epinephrine administration β biphasic effect on blood pressure (BP).
- Mnemonic: ACBD
- AC β High price β high dose adrenaline β ββ BP β a curve
- BD β Beedi β Low price β low dose β ββ BP β b curve
- High concentrations of adrenaline:
- Ξ±1 receptors β vasoconstriction β ββ BP.
- a curve
- Low concentrations of adrenaline:
- Ξ²2 receptors β vasodilation β ββ BP.
- b curve
4. Vasomotor Reversal of Dale

- Epinephrine + Ξ±-blocker (Phentolamine):
- Only Ξ² action observed β vasodilation β β BP
5. Vasomotor Re-reversal of Dale

- Epinephrine + Ξ²-blocker:
- Unopposed Ξ± action observed β ββ vasoconstriction
- Steep rise in BP.
- Applied aspect:
- In Pheochromocytoma,
- Alpha before Ξ² Blocker
6. Effect on Heart Rate (HR) and Blood Pressure (BP)
- Factors influencing:
- Systolic BP
- Directly proportional
- to cardiac contractility.
- to preload (increased by vasoconstriction).
- Diastolic BP
- Directly proportional to
- tone of peripheral blood vessels.


2. Dog Blood Pressure Experiment


- Ephedrine given β BP β β Same dose is repeated β Less β in BP β Called Tachyphylaxis


Autonomic Drugs and Clinical Uses Summary


System | Drug(s) | Clinical Use / Condition | γ
€ |
CNS | Donepezil | Alzheimer's disease | γ
€ |
γ
€ | Scopolamine | Narcoanalysis | γ
€ |
γ
€ | Ξ²-blockers | Depression, insomnia, nightmares (s/e) | γ
€ |
Pupil | Pilocarpine | Closed-angle glaucoma (DOC) | γ
€ |
γ
€ | Phenylephrine, Ephedrine | Mydriasis (No cycloplegia) | γ
€ |
γ
€ | Tropicamide, Atropine, Cyclopentolate, Homatropine | Fundus exam, uveitis, refractive testing | γ
€ |
Oropharyngeal | Pilocarpine, Cevimeline | Xerostomia in Sjogren syndrome | γ
€ |
γ
€ | Glycopyrrolate | Pre-anesthetic (β aspiration risk) | γ
€ |
Bronchi | Tiotropium (DOC), Umeclidinium, Aclinidium, Ipratropium | COPD | γ
€ |
γ
€ | Salbutamol, Terbutaline, Formoterol, Salmeterol | Asthma, COPD (Relievers) | γ
€ |
γ
€ | Olodaterol, Vilanterol, Carmoterol | COPD (vLABA) | γ
€ |
Heart | Ξ²-blockers | AF/flutter, HOCM, Aortic dissection | γ
€ |
γ
€ | Atropine | AV block, bradycardia (DOC) | γ
€ |
γ
€ | Epinephrine | Bradycardia (children), cardiac arrest | γ
€ |
GIT | Bethanechol, Neostigmine | Gastroparesis, Post-op ileus | Bethany β New Bra and My ass |
γ
€ | Pirenzepine, Telenzepine, Dicyclomine, Scopolamine | Peptic ulcer, antispasmodic use | γ
€ |
γ
€ | Phenoxybenzamine | Pheochromocytoma (Pre-op DOC) | γ
€ |
γ
€ | Phentolamine | Cheese reaction, Clonidine withdrawal | Cloned cheese in my pants |
γ
€ | Prazosin | Scorpion bite (DOC) | γ
€ |
γ
€ | Ξ²-blockers | HTN in young | γ
€ |
Bladder | Bethanechol, Neostigmine | Post-op retention, bladder atony | γ
€ |
γ
€ | Solefenib, Flavoxate, Fesoterodine, Darifenacin, Oxybutynin, Tolterodine, Trospium | Overactive bladder | Flavor ulla Feni kudichitt Soli de Tholil keri |
γ
€ | Mirabegron (Ξ²3 agonist) | DOC β Overactive bladder | γ
€ |
γ
€ | Duloxetine | Stress incontinence | Duly stressed |
Skeletal Muscle | Edrophonium | Dx of MG (Tensilon test), crisis differentiation | γ
€ |
γ
€ | Neostigmine | MG management, Cobra bite, After surgery NDMR reversal Post Op urinary retention Postop ileus | γ
€ |
γ
€ | Pyridostigmine | DOC β MG | γ
€ |
γ
€ | Clenbuterol | Performance enhancer (banned) | γ
€ |
Bronchodilation: Inhalation Route of Administration
Pressurized Metered Dose Inhaler (PMDI)


- Gas:
- HydroxyFluoro Alkali (HFA)
- Mechanism
- Placed in mouth
- Canister pressed
- Release of drug
- Coincides with inspiration
- S/E:
- Drug deposition in the oropharynx
Nebulizer (Ipratropium)

- Application
- Inhalable mist
- For acute exacerbation of asthma/COPD
- Components
- High air flow
- Container for drug solution
Side Effect: Paradoxical Bronchoconstriction
- Causes
- Hypotonic solution
- Avoid
- Use isotonic solution
- Bromide
- Blocking of presynaptic m2 (autoreceptor)
- Increases Ach
- Stimulates postsynaptic m3
- Leads to bronchoconstriction
- Excipients like EDTA and Benzalkonium chloride